Seeking Alpha

Cubist Pharmaceuticals (CBST +3.1%) moves up today after reporting an in-line Q4 on a 16% jump...

Cubist Pharmaceuticals (CBST +3.1%) moves up today after reporting an in-line Q4 on a 16% jump in total sales. Net earnings more than quintupled however, as the drug developer racked up much stronger sales, and last year's results were weighed down by higher income-tax provisions. Sales of Cubicin, an intravenous antibiotic for skin and bloodstream infections, jumped 14% to $216M in the U.S.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|